x
Filter:
Filters applied
- Regular Research Articles
- CERemove CE filter
- DGRemove DG filter
Publication Date
Please choose a date range between 2021 and 2022.
Author
- Ackerman, Jacobo Miranda1
- Brosch, Mario1
- Buch, Stephan1
- Burgers, Peter C1
- Coskun, Ünal1
- Dane, Adriaan D1
- Geley, Stephan1
- Gijsen, Frank JH1
- Golderer, Georg1
- Gross, Justus1
- Hampe, Jochen1
- Hartler, Jürgen1
- Has, Canan1
- Heijs, Bram1
- Keller, Markus A1
- Klein, Theo1
- Klipp, Edda1
- Knittelfelder, Oskar1
- Koch, Jakob1
- Köfeler, Harald C1
- Lackner, Katharina1
- Luider, Theo M1
- Moerman, Astrid M1
- Palladini, Alessandra1
- Pauling, Josch Konstantin1
Regular Research Articles
3 Results
- Research ArticleOpen Access
Adaptations of the 3T3-L1 adipocyte lipidome to defective ether lipid catabolism upon Agmo knockdown
Journal of Lipid ResearchVol. 63Issue 6100222Published online: May 7, 2022- Sabrina Sailer
- Katharina Lackner
- Mia L. Pras-Raves
- Eric J.M. Wever
- Jan B. van Klinken
- Adriaan D. Dane
- and others
Cited in Scopus: 0Little is known about the physiological role of alkylglycerol monooxygenase (AGMO), the only enzyme capable of cleaving the 1-O-alkyl ether bond of ether lipids. Expression and enzymatic activity of this enzyme can be detected in a variety of tissues including adipose tissue. This labile lipolytic membrane-bound protein uses tetrahydrobiopterin as a cofactor, and mice with reduced tetrahydrobiopterin levels have alterations in body fat distribution and blood lipid concentrations. In addition, manipulation of AGMO in macrophages led to significant changes in the cellular lipidome, and alkylglycerolipids, the preferred substrates of AGMO, were shown to accumulate in mature adipocytes. - Research ArticleOpen Access
Nonalcoholic fatty liver disease stratification by liver lipidomics
Journal of Lipid ResearchVol. 62100104Published online: August 9, 2021- Olga Vvedenskaya
- Tim Daniel Rose
- Oskar Knittelfelder
- Alessandra Palladini
- Judith Andrea Heidrun Wodke
- Kai Schuhmann
- and others
Cited in Scopus: 18Nonalcoholic fatty liver disease (NAFLD) is a common metabolic dysfunction leading to hepatic steatosis. However, NAFLD's global impact on the liver lipidome is poorly understood. Using high-resolution shotgun mass spectrometry, we quantified the molar abundance of 316 species from 22 major lipid classes in liver biopsies of 365 patients, including nonsteatotic patients with normal or excessive weight, patients diagnosed with NAFL (nonalcoholic fatty liver) or NASH (nonalcoholic steatohepatitis), and patients bearing common mutations of NAFLD-related protein factors. - Research ArticleOpen Access
Lipid signature of advanced human carotid atherosclerosis assessed by mass spectrometry imaging
Journal of Lipid ResearchVol. 62100020Published online: January 5, 2021- Astrid M. Moerman
- Mirjam Visscher
- Nuria Slijkhuis
- Kim Van Gaalen
- Bram Heijs
- Theo Klein
- and others
Cited in Scopus: 0Carotid atherosclerosis is a risk factor for ischemic stroke, one of the main causes of mortality and disability worldwide. The disease is characterized by plaques, heterogeneous deposits of lipids, and necrotic debris in the vascular wall, which grow gradually and may remain asymptomatic for decades. However, at some point a plaque can evolve to a high-risk plaque phenotype, which may trigger a cerebrovascular event. Lipids play a key role in the development and progression of atherosclerosis, but the nature of their involvement is not fully understood.